At the end of 72 weeks, the change in the ratio of total fat mass to lean mass was 0.24 for tirzepatide versus 0.06 for placebo, indicating a greater improvement with tirzepatide [67]
Reflections from a diabetes care editors expert forum
One of the intended effects of GLP-1 agonist medications is to slow down the digestive tract, explains University of Colorado Cancer Center member Swati Patel, associate professor of gastroenterology
Their rich nutrient profile also assists in skin hydration and elasticity
CMS , Medicare GLP-1 Bridge Program (Dec 2025 announcement) Medicare GLP-1 obesity coverage via demonstration starting July 2026 ( [18] )
We may refuse, hide or remove reviews containing insults, threats, discriminatory language, personal data, spam, content unrelated to the product or serious statements that cannot reasonably be verified